{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:31:32Z","timestamp":1789011092087,"version":"build-2803163510"},"reference-count":42,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Burkitt lymphoma (BL) is an aggressive lymphoma type that is currently treated by intensive chemoimmunotherapy. Despite the favorable clinical outcome for most patients with BL, chemotherapy-related toxicity and disease relapse remain major clinical challenges, emphasizing the need for innovative therapies. Using genome-scale CRISPR-Cas9 screens, we identified B-cell receptor (BCR) signaling, specific transcriptional regulators, and one-carbon metabolism as vulnerabilities in BL. We focused on serine hydroxymethyltransferase 2 (SHMT2), a key enzyme in one-carbon metabolism. Inhibition of SHMT2 by either knockdown or pharmacological compounds induced anti-BL effects in\u00a0vitro and in\u00a0vivo. Mechanistically, SHMT2 inhibition led to a significant reduction of intracellular glycine and formate levels, which inhibited the mTOR pathway and thereby triggered autophagic degradation of the oncogenic transcription factor TCF3. Consequently, this led to a collapse of tonic BCR signaling, which is controlled by TCF3 and is essential for BL cell survival. In terms of clinical translation, we also identified drugs such as methotrexate that synergized with SHMT inhibitors. Overall, our study has uncovered the dependency landscape in BL, identified and validated SHMT2 as a drug target, and revealed a mechanistic link between SHMT2 and the transcriptional master regulator TCF3, opening up new perspectives for innovative therapies.<\/jats:p>","DOI":"10.1182\/blood.2021012081","type":"journal-article","created":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T23:59:09Z","timestamp":1633910349000},"page":"538-553","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":48,"title":["SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma"],"prefix":"10.1182","volume":"139","author":[{"given":"Anne C.","family":"Wilke","sequence":"first","affiliation":[{"name":"Department of Medicine II, Department for Hematology\/Oncology, Goethe University, Frankfurt, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Doebele","sequence":"additional","affiliation":[{"name":"Department of Medicine II, Department for Hematology\/Oncology, Goethe University, Frankfurt, Germany;"},{"name":"German Cancer Research Center and German Cancer Consortium, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena","family":"Zindel","sequence":"additional","affiliation":[{"name":"Department of Medicine II, Department for Hematology\/Oncology, Goethe University, Frankfurt, Germany;"},{"name":"German Cancer Research Center and German Cancer Consortium, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7682-5736","authenticated-orcid":false,"given":"Kwang Seok","family":"Lee","sequence":"additional","affiliation":[{"name":"Molecular Therapy in Haematology and Oncology and Department of Translational Oncology, NCT and DKFZ, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2890-1308","authenticated-orcid":false,"given":"Sara A.","family":"Rieke","sequence":"additional","affiliation":[{"name":"Department of Medicine II, Department for Hematology\/Oncology, Goethe University, Frankfurt, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Ceribelli","sequence":"additional","affiliation":[{"name":"Division of Pre-Clinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, Rockville, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8970-6610","authenticated-orcid":false,"given":"Federico","family":"Comoglio","sequence":"additional","affiliation":[{"name":"enGene Statistics GmbH, Basel, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Phelan","sequence":"additional","affiliation":[{"name":"Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Q.","family":"Wang","sequence":"additional","affiliation":[{"name":"Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yana","family":"Pikman","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Jahn","sequence":"additional","affiliation":[{"name":"Department of Medicine II, Department for Hematology\/Oncology, Goethe University, Frankfurt, Germany;"},{"name":"German Cancer Research Center and German Cancer Consortium, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"H\u00e4upl","sequence":"additional","affiliation":[{"name":"Department of Medicine II, Department for Hematology\/Oncology, Goethe University, Frankfurt, Germany;"},{"name":"German Cancer Research Center and German Cancer Consortium, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constanze","family":"Schneider","sequence":"additional","affiliation":[{"name":"Department of Medicine II, Department for Hematology\/Oncology, Goethe University, Frankfurt, Germany;"},{"name":"Division of Hematology\/Oncology, Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA;"},{"name":"Frankfurt Cancer Institute, Goethe University Frankfurt, Frankfurt, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Scheich","sequence":"additional","affiliation":[{"name":"Department of Medicine II, Department for Hematology\/Oncology, Goethe University, Frankfurt, Germany;"},{"name":"Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances A.","family":"Tosto","sequence":"additional","affiliation":[{"name":"Division of Pre-Clinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, Rockville, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1038-1030","authenticated-orcid":false,"given":"Hanibal","family":"Bohnenberger","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3876-6023","authenticated-orcid":false,"given":"Philipp","family":"Stauder","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2426-6685","authenticated-orcid":false,"given":"Frank","family":"Schn\u00fctgen","sequence":"additional","affiliation":[{"name":"Department of Medicine II, Department for Hematology\/Oncology, Goethe University, Frankfurt, Germany;"},{"name":"German Cancer Research Center and German Cancer Consortium, Heidelberg, Germany;"},{"name":"Frankfurt Cancer Institute, Goethe University Frankfurt, Frankfurt, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikolaj","family":"Slabicki","sequence":"additional","affiliation":[{"name":"Molecular Therapy in Haematology and Oncology and Department of Translational Oncology, NCT and DKFZ, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zana A.","family":"Coulibaly","sequence":"additional","affiliation":[{"name":"Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Wolf","sequence":"additional","affiliation":[{"name":"Department of Medicine II, Department for Hematology\/Oncology, Goethe University, Frankfurt, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamil","family":"Bojarczuk","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Georg August University, G\u00f6ttingen, Germany;"},{"name":"Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6485-8773","authenticated-orcid":false,"given":"Bj\u00f6rn","family":"Chapuy","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Georg August University, G\u00f6ttingen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1732-2535","authenticated-orcid":false,"given":"Christian H.","family":"Brandts","sequence":"additional","affiliation":[{"name":"Department of Medicine II, Department for Hematology\/Oncology, Goethe University, Frankfurt, Germany;"},{"name":"German Cancer Research Center and German Cancer Consortium, Heidelberg, Germany;"},{"name":"Frankfurt Cancer Institute, Goethe University Frankfurt, Frankfurt, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8528-8060","authenticated-orcid":false,"given":"Philipp","family":"Stroebel","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline A.","family":"Lewis","sequence":"additional","affiliation":[{"name":"Whitehead Institute for Biomedical Research, Cambridge, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Engelke","sequence":"additional","affiliation":[{"name":"Institute of Cellular and Molecular Immunology, Georg August University of G\u00f6ttingen, G\u00f6ttingen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1062-2092","authenticated-orcid":false,"given":"Xincheng","family":"Xu","sequence":"additional","affiliation":[{"name":"Lewis-Sigler Institute for Integrative Genomics,"},{"name":"Department of Chemistry, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hahn","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Chemistry, and"},{"name":"Princeton University Small Molecule Screening Center, Princeton University, Princeton, NJ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh Hung","family":"Dang","sequence":"additional","affiliation":[{"name":"Institute for Pathology, Molecular Cytology and Functional Genomics, University Hospital Giessen, Giessen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3348-6807","authenticated-orcid":false,"given":"Roland","family":"Schmitz","sequence":"additional","affiliation":[{"name":"Institute for Pathology, Molecular Cytology and Functional Genomics, University Hospital Giessen, Giessen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6225-2033","authenticated-orcid":false,"given":"Daniel J.","family":"Hodson","sequence":"additional","affiliation":[{"name":"Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Stegmaier","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Urlaub","sequence":"additional","affiliation":[{"name":"Bioanalytical Mass Spectrometry Group, Max Planck Institute for Biophysical Chemistry, G\u00f6ttingen, Germany;"},{"name":"Bioanalytics, Georg August University, G\u00f6ttingen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8472-5516","authenticated-orcid":false,"given":"Hubert","family":"Serve","sequence":"additional","affiliation":[{"name":"Department of Medicine II, Department for Hematology\/Oncology, Goethe University, Frankfurt, Germany;"},{"name":"German Cancer Research Center and German Cancer Consortium, Heidelberg, Germany;"},{"name":"Frankfurt Cancer Institute, Goethe University Frankfurt, Frankfurt, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4731-2226","authenticated-orcid":false,"given":"Clemens A.","family":"Schmitt","sequence":"additional","affiliation":[{"name":"German Cancer Research Center and German Cancer Consortium, Heidelberg, Germany;"},{"name":"Charit\u00e9-University Medical Center, Department of Hematology, Oncology and Tumor Immunology, Virchow Campus, and Molekulares Krebsforschungszentrum, Berlin, Germany;"},{"name":"Max Delbr\u00fcck Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany;"},{"name":"Department of Hematology and Oncology, Kepler University Hospital, Johannes Kepler University, Linz, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Kreuz","sequence":"additional","affiliation":[{"name":"Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, and"},{"name":"Center for Integrated Oncology, University of Cologne, Cologne, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8395-3701","authenticated-orcid":false,"given":"Gero","family":"Knittel","sequence":"additional","affiliation":[{"name":"Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, and"},{"name":"Center for Integrated Oncology, University of Cologne, Cologne, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1247-4727","authenticated-orcid":false,"given":"Joshua D.","family":"Rabinowitz","sequence":"additional","affiliation":[{"name":"Lewis-Sigler Institute for Integrative Genomics,"},{"name":"Department of Chemistry, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Christian","family":"Reinhardt","sequence":"additional","affiliation":[{"name":"German Cancer Research Center and German Cancer Consortium, Heidelberg, Germany;"},{"name":"Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew G.","family":"Vander Heiden","sequence":"additional","affiliation":[{"name":"Koch Institute for Cancer Research at MIT, Cambridge, MA;"},{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Thomas","sequence":"additional","affiliation":[{"name":"Division of Pre-Clinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, Rockville, MD;"},{"name":"Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis M.","family":"Staudt","sequence":"additional","affiliation":[{"name":"Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Zenz","sequence":"additional","affiliation":[{"name":"Molecular Therapy in Haematology and Oncology and Department of Translational Oncology, NCT and DKFZ, Heidelberg, Germany;"},{"name":"Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6570-6125","authenticated-orcid":false,"given":"Thomas","family":"Oellerich","sequence":"additional","affiliation":[{"name":"Department of Medicine II, Department for Hematology\/Oncology, Goethe University, Frankfurt, Germany;"},{"name":"German Cancer Research Center and German Cancer Consortium, Heidelberg, Germany;"},{"name":"Frankfurt Cancer Institute, Goethe University Frankfurt, Frankfurt, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"15","key":"2022012716231861100_B1","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMra0807082","article-title":"Aggressive lymphomas","volume":"362","author":"Lenz","year":"2010","journal-title":"N Engl J Med."},{"issue":"20","key":"2022012716231861100_B2","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa1308392","article-title":"Low-intensity therapy in adults with Burkitt\u2019s lymphoma","volume":"369","author":"Dunleavy","year":"2013","journal-title":"N Engl J Med."},{"issue":"26","key":"2022012716231861100_B3","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1182\/blood-2014-03-563627","article-title":"Improved outcome of adult Burkitt lymphoma\/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial","volume":"124","author":"Hoelzer","year":"2014","journal-title":"Blood."},{"issue":"6","key":"2022012716231861100_B4","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/bjh.15262","article-title":"Excellent real-world outcomes of adults with Burkitt lymphoma treated with CODOX-M\/IVAC plus or minus rituximab","volume":"181","author":"Zhu","year":"2018","journal-title":"Br J Haematol."},{"issue":"24","key":"2022012716231861100_B5","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1182\/blood-2012-12-475558","article-title":"Trends in survival of patients with Burkitt lymphoma\/leukemia in the USA: an analysis of 3691 cases","volume":"121","author":"Costa","year":"2013","journal-title":"Blood."},{"issue":"9","key":"2022012716231861100_B6","doi-asserted-by":"crossref","first-page":"e27873","DOI":"10.1002\/pbc.27873","article-title":"Outcome of relapse in children and adolescents with B-cell non-Hodgkin lymphoma and mature acute leukemia: a report from the French LMB study","volume":"66","author":"Rigaud","year":"2019","journal-title":"Pediatr Blood Cancer."},{"issue":"24","key":"2022012716231861100_B7","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.1073\/pnas.79.24.7824","article-title":"Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells","volume":"79","author":"Dalla-Favera","year":"1982","journal-title":"Proc Natl Acad Sci USA."},{"issue":"24","key":"2022012716231861100_B8","doi-asserted-by":"crossref","first-page":"7837","DOI":"10.1073\/pnas.79.24.7837","article-title":"Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells","volume":"79","author":"Taub","year":"1982","journal-title":"Proc Natl Acad Sci USA."},{"issue":"6","key":"2022012716231861100_B9","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1371\/journal.pbio.0060152","article-title":"The B cell antigen receptor and overexpression of MYC can cooperate in the genesis of B cell lymphomas","volume":"6","author":"Refaeli","year":"2008","journal-title":"PLoS Biol."},{"issue":"2","key":"2022012716231861100_B10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccr.2012.06.012","article-title":"Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis","volume":"22","author":"Sander","year":"2012","journal-title":"Cancer Cell."},{"issue":"7418","key":"2022012716231861100_B11","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11378","article-title":"Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics","volume":"490","author":"Schmitz","year":"2012","journal-title":"Nature."},{"issue":"19","key":"2022012716231861100_B12","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1182\/blood.2019001880","article-title":"The whole-genome landscape of Burkitt lymphoma subtypes","volume":"134","author":"Panea","year":"2019","journal-title":"Blood."},{"issue":"5","key":"2022012716231861100_B13","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/1097-0142(196305)16:5<616::AID-CNCR2820160512>3.0.CO;2-U","article-title":"Malignant lymphoma involving the jaw in African children: treatment with Methotrexate","volume":"16","author":"Oettgen","year":"1963","journal-title":"Cancer."},{"issue":"12","key":"2022012716231861100_B14","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1200\/JCO.1986.4.12.1732","article-title":"Results of treatment of advanced-stage Burkitt\u2019s lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine","volume":"4","author":"Murphy","year":"1986","journal-title":"J Clin Oncol."},{"issue":"43","key":"2022012716231861100_B15","doi-asserted-by":"crossref","first-page":"11404","DOI":"10.1073\/pnas.1706617114","article-title":"Human SHMT inhibitors reveal defective glycine import as a targetable metabolic vulnerability of diffuse large B-cell lymphoma","volume":"114","author":"Ducker","year":"2017","journal-title":"Proc Natl Acad Sci USA."},{"issue":"1","key":"2022012716231861100_B16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2016.08.009","article-title":"One-carbon metabolism in health and disease","volume":"25","author":"Ducker","year":"2017","journal-title":"Cell Metab."},{"issue":"10","key":"2022012716231861100_B17","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nrc.2016.81","article-title":"Serine and one-carbon metabolism in cancer","volume":"16","author":"Yang","year":"2016","journal-title":"Nat Rev Cancer."},{"issue":"7718","key":"2022012716231861100_B18","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41586-018-0290-0","article-title":"A multiprotein supercomplex controlling oncogenic signalling in lymphoma","volume":"560","author":"Phelan","year":"2018","journal-title":"Nature."},{"issue":"4","key":"2022012716231861100_B19","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ccell.2017.03.001","article-title":"Hoxa9 and Meis1 cooperatively induce addiction to Syk signaling by suppressing miR-146a in acute myeloid leukemia","volume":"31","author":"Mohr","year":"2017","journal-title":"Cancer Cell."},{"issue":"2","key":"2022012716231861100_B20","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41375-020-0845-6","article-title":"SHMT inhibition is effective and synergizes with methotrexate in T-cell acute lymphoblastic leukemia","volume":"35","author":"Garc\u00eda-Ca\u00f1averas","year":"2021","journal-title":"Leukemia."},{"issue":"10","key":"2022012716231861100_B21","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1158\/1535-7163.MCT-19-0037","article-title":"Novel pyrrolo[3,2-d]pyrimidine compounds target mitochondrial and cytosolic one-carbon metabolism with broad-spectrum antitumor efficacy","volume":"18","author":"Dekhne","year":"2019","journal-title":"Mol Cancer Ther."},{"issue":"6","key":"2022012716231861100_B22","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.celrep.2013.11.020","article-title":"An optimized microRNA backbone for effective single-copy RNAi","volume":"5","author":"Fellmann","year":"2013","journal-title":"Cell Rep."},{"issue":"7547","key":"2022012716231861100_B23","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nature14363","article-title":"SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance","volume":"520","author":"Kim","year":"2015","journal-title":"Nature."},{"issue":"4","key":"2022012716231861100_B24","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.molcel.2018.01.024","article-title":"Serine catabolism by SHMT2 is required for proper mitochondrial translation initiation and maintenance of formylmethionyl-tRNAs","volume":"69","author":"Minton","year":"2018","journal-title":"Mol Cell."},{"issue":"12","key":"2022012716231861100_B25","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/ng.2468","article-title":"The genetic landscape of mutations in Burkitt lymphoma","volume":"44","author":"Love","year":"2012","journal-title":"Nat Genet."},{"issue":"12","key":"2022012716231861100_B26","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1182\/blood-2018-09-871418","article-title":"Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma","volume":"133","author":"Grande","year":"2019","journal-title":"Blood."},{"issue":"16","key":"2022012716231861100_B27","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1182\/blood-2017-02-767335","article-title":"Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets","volume":"130","author":"Bouska","year":"2017","journal-title":"Blood."},{"issue":"1","key":"2022012716231861100_B28","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/s41467-019-08578-3","article-title":"Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma","volume":"10","author":"L\u00f3pez","year":"2019","journal-title":"Nat Commun."},{"issue":"20","key":"2022012716231861100_B29","doi-asserted-by":"crossref","first-page":"5688","DOI":"10.1073\/pnas.1601053113","article-title":"Elucidation of tonic and activated B-cell receptor signaling in Burkitt\u2019s lymphoma provides insights into regulation of cell survival","volume":"113","author":"Corso","year":"2016","journal-title":"Proc Natl Acad Sci USA."},{"issue":"8","key":"2022012716231861100_B30","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1128\/MCB.16.8.4117","article-title":"Membrane localization of phosphatidylinositol 3-kinase is sufficient to activate multiple signal-transducing kinase pathways","volume":"16","author":"Klippel","year":"1996","journal-title":"Mol Cell Biol."},{"issue":"9","key":"2022012716231861100_B31","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41580-018-0033-y","article-title":"Autophagy as a promoter of longevity: insights from model organisms [published correction appears in Nat Rev Mol Cell Biol. 2018;19:611]","volume":"19","author":"Hansen","year":"2018","journal-title":"Nat Rev Mol Cell Biol."},{"issue":"4","key":"2022012716231861100_B32","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4161\/auto.19496","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy","volume":"8","author":"Klionsky","year":"2012","journal-title":"Autophagy."},{"issue":"4","key":"2022012716231861100_B33","doi-asserted-by":"crossref","first-page":"e2007044","DOI":"10.1371\/journal.pbio.2007044","article-title":"CRISPR screening using an expanded toolkit of autophagy reporters identifies TMEM41B as a novel autophagy factor","volume":"17","author":"Shoemaker","year":"2019","journal-title":"PLoS Biol."},{"issue":"1","key":"2022012716231861100_B34","first-page":"125","article-title":"Dramatic antitumor effects of the dual mTORC1 and mTORC2 inhibitor AZD2014 in hepatocellular carcinoma","volume":"5","author":"Liao","year":"2014","journal-title":"Am J Cancer Res."},{"issue":"16","key":"2022012716231861100_B35","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1080\/15384101.2015.1056947","article-title":"Cellular adaptation to nutrient deprivation: crosstalk between the mTORC1 and eIF2\u03b1 signaling pathways and implications for autophagy","volume":"14","author":"Wengrod","year":"2015","journal-title":"Cell Cycle."},{"issue":"1","key":"2022012716231861100_B36","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cellsig.2012.09.020","article-title":"Starvation-induced autophagy is regulated by mitochondrial reactive oxygen species leading to AMPK activation","volume":"25","author":"Li","year":"2013","journal-title":"Cell Signal."},{"key":"2022012716231861100_B37","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/978-1-4939-9151-8_18","article-title":"Proximity ligation assay","volume":"1956","author":"Young","year":"2019","journal-title":"Methods Mol Biol."},{"issue":"16","key":"2022012716231861100_B38","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1101\/gad.1815309","article-title":"The combined status of ATM and p53 link tumor development with therapeutic response","volume":"23","author":"Jiang","year":"2009","journal-title":"Genes Dev."},{"issue":"3","key":"2022012716231861100_B39","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/s41375-019-0618-2","article-title":"ATM activity in T cells is critical for immune surveillance of lymphoma in\u00a0vivo","volume":"34","author":"Riabinska","year":"2020","journal-title":"Leukemia."},{"key":"2022012716231861100_B40","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1182\/blood.2020005244","article-title":"Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomas","volume":"137","author":"Reimann","year":"2020","journal-title":"Blood."},{"issue":"1","key":"2022012716231861100_B41","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1158\/2643-3230.BCD-19-0059","article-title":"An autochthonous mouse model of Myd88- and BCL2-driven diffuse large B cell lymphoma reveals actionable molecular vulnerabilities","volume":"2","author":"Fl\u00fcmann","year":"2021","journal-title":"Blood Cancer Discov."},{"issue":"5","key":"2022012716231861100_B42","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1038\/s41596-021-00506-4","article-title":"Genetic manipulation and immortalized culture of ex vivo primary human germinal center B cells","volume":"16","author":"Caeser","year":"2021","journal-title":"Nat Protoc."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/139\/4\/538\/1864290\/bloodbld2021012081.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/139\/4\/538\/1864290\/bloodbld2021012081.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T16:24:55Z","timestamp":1643300695000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/139\/4\/538\/477215\/SHMT2-inhibition-disrupts-the-TCF3-transcriptional"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,27]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,1,27]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2021012081","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,27]]}}}